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SHORT COMMUNICATION
The effects of 30 days resveratrol supplementation on adipose
tissue morphology and gene expression patterns in obese men
E Konings1,5, S Timmers1,2,5, MV Boekschoten3,4, GH Goossens1, JW Jocken1, LA Afman3,4, M Müller3,4, P Schrauwen1,2, EC Mariman1 and
EE Blaak1
Polyphenolic compounds, such as resveratrol, have recently received widespread interest because of their ability to mimic effects
of calorie restriction. The objective of the present study was to gain more insight into the effects of 30 days resveratrol
supplementation on adipose tissue morphology and underlying processes. Eleven healthy obese men were supplemented with
placebo and resveratrol for 30 days (150mg per day), separated by a 4-week washout period in a double-blind randomized
crossover design. A postprandial abdominal subcutaneous adipose tissue biopsy was collected to assess adipose tissue morphology
and gene expression using microarray analysis. Resveratrol significantly decreased adipocyte size, with a shift toward a reduction in
the proportion of large and very-large adipocytes and an increase in small adipocytes. Microarray analysis revealed downregulation
of Wnt and Notch signaling pathways and upregulation of pathways involved in cell cycle regulation after resveratrol
supplementation, suggesting enhanced adipogenesis. Furthermore, lysosomal/phagosomal pathway and transcription factor EB
were upregulated reflecting an alternative pathway of lipid breakdown by autophagy. Further research is necessary to investigate
whether resveratrol improves adipose tissue function.
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INTRODUCTION
Obesity is reaching epidemic proportions and is associated with
insulin resistance and an increased risk for type 2 diabetes
mellitus.1 Polyphenolic compounds, such as resveratrol, are
currently an area of intense investigation because of their ability
to mimic effects of calorie restriction. Pronounced effects of
resveratrol have been reported on lipolysis, adipogenesis and
inflammation in isolated adipocytes and on adipose tissue of
murine animals.2 These effects may possibly reflect changes in
adipose tissue function and an improved insulin sensitivity.3
On the other hand, a mice study with resveratrol showed an
inhibition of adipogenesis.4 Although the latter finding has been
implicated in the prevention of body fat accumulation in this
study, this may also reflect impaired adipogenic potential resulting
in a reduced adipose tissue expandability and insulin resistance.5
A recent human study observed no changes in adipose tissue
mass (total, subcutaneous or visceral fat), adipose tissue or muscle
metabolic and inflammatory gene expression profiles and insulin
sensitivity after 4 weeks of a high daily dose of resveratrol
(1500mg per day) in obese healthy men.6 In another study of
Yoshino et al. in non-obese postmenopausal women, resveratrol
supplementation (75mg per day) did not affect liver, muscle or
adipose tissue insulin sensitivity or its putative molecular targets in
adipose tissue or muscle.7 In contrast, in a recent study in our
laboratory, it was shown that resveratrol supplementation for 4
weeks (150mg per day) induced metabolic changes in liver and
skeletal muscle metabolism in obese humans, mimicking the
effects of calorie restriction.8 These data may suggest that the
resveratrol-induced metabolic effects may depend on the
administered dose or to what extent the metabolic state is
compromised.
The general aim of the present work was to gain more insight
into the effects of 30 days resveratrol supplementation (150mg
per day) on adipose tissue morphology and the transcriptional
profile using microarray analysis in healthy obese men.
PATIENTS AND METHODS
Study design
The current study was part of a previously published randomized double-
blind crossover study.8 Eleven obese, healthy men participated in two trials
for 30 days: a placebo and resVida (150mg per day trans-resveratrol
(99.9%; DSM Nutritional Products, Kaiseraugst, Switzerland)) condition,
with a 4-week washout period. At the end of both intervention periods, a
subcutaneous adipose tissue biopsy was taken 6 h after ingestion of a
high-fat liquid test meal.8 The original study protocol was approved by the
Medical Ethical Committee of Maastricht University Medical Center and
written informed consent was obtained before study participation.
Abdominal subcutaneous adipocyte size
Processing and analysis of subcutaneous adipose tissue biopsies for
adipocyte size have been described in detail previously.9 Briefly, an
adipose tissue needle biopsy (B1 g) was collected 6–8 cm lateral from the
umbilicus. Part of the adipose tissue was fixed overnight in 4%
paraformaldehyde and embedded in paraffin for histological sections
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(8mm), whereas the other part was snap frozen in liquid nitrogen and
stored at  80 1C. Sections were stained with hematoxylin and eosin.
Digital images were captured and computerized morphometric analysis of
individual adipocytes was performed in a blinded manner.
Adipose tissue gene expression
Microarray processing. Total RNA was extracted from frozen adipose
tissue specimens using TRIzol reagent (Invitrogen, Breda, The Netherlands)
and purified on columns using the Qiagen RNeasy Micro Kit (Qiagen,
Venlo, The Netherlands). Total RNA (100 ng per sample) was labeled by
Whole-Transcript Sense Target Assay and hybridized to human
whole-genome Affymetrix Gene 1.1 ST arrays targeting 19 793 unique
genes (Affymetrix, Santa Clara, CA, USA).
Microarray data analysis. Quality control and data analysis have been
described in detail previously.8 Individual genes were defined as changed
when comparison of the normalized signal intensities showed a P-value
o0.05 in a two-tailed paired intensity-based moderated t-statistics
(PMID:17177995). These analyses were performed within MADMAX
system (PMID:21778530). Further functional data analysis was performed
on the filtered data set (45 arrays with signal intensity 420) with Gene
Set Enrichment Analysis (http://www.broad.mit.edu/gsea/) and gene sets
were selected based upon a FDR q-value o0.25. A transcription factor
analysis was performed on the differentially expressed genes (P-value
o0.05) with Ingenuity Pathway Analysis (June 2012, Ingenuity Systems,
Redwood City, CA, USA). Array data have been submitted to the Gene
Expression Omnibus GSE42432.
Statistics
Student’s paired t-test was used to compare placebo and resveratrol
supplementation in normally distributed data. A P-value o0.05 was
considered statistically significant. Data are reported as mean±s.e.m.
Statistical analyses were performed using the statistical program SPSS 16.0
(SPSS Inc., Chicago, IL, USA).
RESULTS
Subject characteristics
Eleven obese male volunteers aged 40–65 years and body mass
index between 28 and 36 kgm 2 participated in this study. Other
subject characteristics and effects of 30 days resveratrol on plasma
biochemistry have previously been reported.8
Resveratrol decreased abdominal subcutaneous adipocyte size
Mean adipocyte size was decreased after 30 days resveratrol
(65.0±4.4mm) compared with placebo (74.7±3.5mm; Figure 1c).
This was attributed by a shift toward a lower proportion of very large
adipocytes (490mm) and an increased proportion of small
adipocytes (o50mm). The proportion of large (70–89mm) adipocytes
also tended to be lower after resveratrol supplementation
(Figure 1d). A representative image is shown in Figures 1a and b.
Microarray analysis
From the 19 793 genes on the array, 12 676 genes were expressed
in adipose tissue. Resveratrol supplementation resulted in
changed expression of 582 genes, of which 290 were upregulated
and 292 were downregulated.
Gene set enrichment analysis
Gene sets that were downregulated by resveratrol belonged to
pathways involved in cell–cell junction, Wnt signaling, angiogen-
esis, G protein coupled receptors and Notch signaling (Figure 2a).
Gene sets upregulated by resveratrol were associated with lysosome,
phagosome, inflammation, glucose/hexose transport and cell cycle
(Figure 2b). Upregulated pathways associated with inflammation
included interferon signaling, antigen processing and presentation,
T-cell receptor signaling and nuclear factor kB activation
(Supplementary Table 1). Core-enriched genes per up- and down-
regulated pathways are presented in Supplementary Table 2.
Transcription factor analysis
Several transcription factors involved in interferon signaling
were identified as potentially activated (Supplementary Table 3).
Furthermore, the nuclear factor kB complex involved in
inflammation, PPARd and transcription factor EB (TFEB), which
links autophagy to lysosomal biogenesis, were shown to be
activated.10
Figure 1. Adipocyte size measurement after placebo and resveratrol supplementation. Representative adipose tissue sections after placebo (a)
and resveratrol (b) supplementation ( 20 magnification). (c) Mean adipocyte diameter. (d) Adipocyte size distribution. N¼ 8. Values are
means±s.e.m. #Po0.1, *Po0.05.
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Transcription factors that were identified as inhibited included
Notch 4 and SMAD4 (Supplementary Table 3). The transcription
factor hypoxia-inducible factor 1-a was also inhibited.
DISCUSSION
Resveratrol significantly decreased adipocyte size, with a shift
toward a lower proportion of large and very large adipocytes and
an increased proportion of small adipocytes. Gene expression
analysis indicated an increased adipogenesis and an altered
pathway of lipid breakdown by autophagy. Together, these data
suggest that the reduced mean adipocyte size may underlie the
previously reported improved insulin sensitivity in these subjects,
as a reduced adipocyte size in combination with an improved
adipogenesis may be related to an improved insulin sensitivity in
humans.11
Microarray analysis indicated that the Wnt signaling and Notch
signaling pathway were downregulated after resveratrol supple-
mentation. Inhibition of these pathways has shown to result in
adipogenesis of preadipocytes and/or multipotent precursor
cells,12,13 although the exact role in adipogenesis needs to be
further elucidated. Gene sets associated with cell cycle were
upregulated by resveratrol. This indicates that an increased
adipogenesis could possibly explain the reduced adipocyte size
after resveratrol. In contrast to our in vivo observations, in vitro
experiments performed in murine and human adipocyte cell lines
have shown that resveratrol inhibited proliferation and adipogenic
differentiation.14,15 The discrepancy between in vitro results and
the present data may be explained by differences in resveratrol
concentrations, acute in vitro vs chronic in vivo administration and
the presence of stromal vascular cell types (for example,
inflammatory cells) in the in vivo situation.
Our data show that the angiogenesis pathway was down-
regulated in human adipose tissue after resveratrol supplementa-
tion. Furthermore, the transcription factor hypoxia-inducible factor
1-a whose activity is induced by hypoxia, insulin and nitric oxide16
was also downregulated. These data are consistent with studies
showing that resveratrol possesses anti-angiogenic effects,17 but
further research is necessary to determine the exact role of
resveratrol on angiogenesis in adipose tissue.
Interestingly, activation of a lysosomal pathway of lipid break-
down was demonstrated. Until recently, mobilization of lipids by
the classic lipolytic pathway has only been attributed to lipid
droplet-associated proteins and lipases. Lately, an alternative
pathway of lipid metabolism has been proposed through the
lysosomal degradative pathway of autophagy. Major support for
the involvement of autophagy is the activation of TFEB following
resveratrol supplementation in the present study. TFEB controls
multiple crucial steps of the autophagic pathway.10 Studies in
hepatocytes and liver have demonstrated lipid breakdown by
autophagy.18 In preadipocytes, inhibition of autophagy has shown
to block adipogenesis.19 Therefore, in the present study, the
lysosome and phagosome pathways, may have contributed both
to an induction of adipogenesis as well as to alternative lipid
breakdown, possibly contributing to the shift toward an increased
proportion of small adipocytes after resveratrol.
In the present study, several pathways involved in the immune
response were upregulated after resveratrol treatment. This may
reflect an increase in cellular stress induced by the reduction in
adipocyte size caused by traction forces between the adipocyte
and the surrounding extracellular matrix. This may induce
upregulation of inflammatory genes and pro-inflammatory
adipokine production, as shown after weight loss.20 On the
other hand, upregulation of immune response pathways may be a
physiological response to a higher lipid turnover (that is,
Figure 2. Up- and downregulated gene sets after resveratrol supplementation using gene set enrichment analysis. (a) Downregulated gene
sets after resveratrol supplementation. (b) Upregulated gene sets after resveratrol supplementation. The z-score was calculated by subtracting
the mean expression value for each transcript from each of the values and then dividing the resulting values by the standard deviation. Only
the core-enriched genes are represented in this figure. Color in the heat-maps reflects the relative transcript abundance level with red being
higher and blue lower than the mean transcript abundance value.
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lysosomal lipid breakdown). We previously observed in these
subjects a decrease in plasma interleukin-6 and tumor necrosis
factor-a concentrations and a downregulation of gene sets
associated with immune response in skeletal muscle following
resveratrol supplementation.8 These findings indicate that the
increased immune response in adipose tissue could represent a
local rather than a systemic response.8
The present results show that resveratrol increased pathways in the
adipose tissue involved in glucose and hexose transport as evidenced
by GSEA. However, in vitro data concerning the effects of resveratrol
on glucose transport are conflicting.15 It needs to be further
established if the observed increase in glucose/hexose transport
pathway, translates into a functional increase in glucose uptake.
As indicated above, resveratrol clearly affected adipose tissue
gene expression profiles. This is in contrast with two recent human
trials, which did not show any effects on adipose tissue metabolism
or gene expression after resveratrol supplementation.6,7 The reason
for this discrepancy may possibly lie in the administered dose,
which was very high in the study of Poulsen et al. (1500mg per day)
as compared with our study or the healthier metabolic status of the
subjects in the study of Yoshino et al.6,7
In conclusion, resveratrol supplementation for 30 days induced
a shift toward an increased proportion of small adipocytes. This
phenotype was accompanied by a gene expression profile
indicative of increased adipogenesis, an alternative pathway of
lipid breakdown by autophagy and an increased immune and
inflammatory response. Further research is necessary to investi-
gate whether resveratrol improves adipose tissue function.
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